A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies

We assessed the sustained delivery effect of poly (lactic-co-glycolic) acid (PLGA)/vitamin E (VitE) microspheres (MSs) loaded with glial cell-derived neurotrophic factor (GDNF) alone (GDNF-MSs) or combined with brain-derived neurotrophic factor (BDNF; GDNF/BDNF-MSs) on migration of the human adult r...

Full description

Bibliographic Details
Main Authors: Alicia Arranz-Romera, Maria Hernandez, Patricia Checa-Casalengua, Alfredo Garcia-Layana, Irene T. Molina-Martinez, Sergio Recalde, Michael J. Young, Budd A. Tucker, Rocío Herrero-Vanrell, Patricia Fernandez-Robredo, Irene Bravo-Osuna
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/1/50
_version_ 1827602216407531520
author Alicia Arranz-Romera
Maria Hernandez
Patricia Checa-Casalengua
Alfredo Garcia-Layana
Irene T. Molina-Martinez
Sergio Recalde
Michael J. Young
Budd A. Tucker
Rocío Herrero-Vanrell
Patricia Fernandez-Robredo
Irene Bravo-Osuna
author_facet Alicia Arranz-Romera
Maria Hernandez
Patricia Checa-Casalengua
Alfredo Garcia-Layana
Irene T. Molina-Martinez
Sergio Recalde
Michael J. Young
Budd A. Tucker
Rocío Herrero-Vanrell
Patricia Fernandez-Robredo
Irene Bravo-Osuna
author_sort Alicia Arranz-Romera
collection DOAJ
description We assessed the sustained delivery effect of poly (lactic-co-glycolic) acid (PLGA)/vitamin E (VitE) microspheres (MSs) loaded with glial cell-derived neurotrophic factor (GDNF) alone (GDNF-MSs) or combined with brain-derived neurotrophic factor (BDNF; GDNF/BDNF-MSs) on migration of the human adult retinal pigment epithelial cell-line-19 (ARPE-19) cells, primate choroidal endothelial (RF/6A) cells, and the survival of isolated mouse retinal ganglion cells (RGCs). The morphology of the MSs, particle size, and encapsulation efficiencies of the active substances were evaluated. In vitro release, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability, terminal deoxynucleotidyl transferase (TdT) deoxyuridine dUTP nick-end labelling (TUNEL) apoptosis, functional wound healing migration (ARPE-19; migration), and (RF/6A; angiogenesis) assays were conducted. The safety of MS intravitreal injection was assessed using hematoxylin and eosin, neuronal nuclei (NeuN) immunolabeling, and TUNEL assays, and RGC in vitro survival was analyzed. MSs delivered GDNF and co-delivered GDNF/BDNF in a sustained manner over 77 days. The BDNF/GDNF combination increased RPE cell migration, whereas no effect was observed on RF/6A. MSs did not alter cell viability, apoptosis was absent in vitro, and RGCs survived in vitro for seven weeks. In mice, retinal toxicity and apoptosis was absent in histologic sections. This delivery strategy could be useful as a potential co-therapy in retinal degenerations and glaucoma, in line with future personalized long-term intravitreal treatment as different amounts (doses) of microparticles can be administered according to patients’ needs.
first_indexed 2024-03-09T05:13:07Z
format Article
id doaj.art-838e65d3e55d473491960920b36130fe
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T05:13:07Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-838e65d3e55d473491960920b36130fe2023-12-03T12:47:18ZengMDPI AGPharmaceuticals1424-82472021-01-011415010.3390/ph14010050A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal PathologiesAlicia Arranz-Romera0Maria Hernandez1Patricia Checa-Casalengua2Alfredo Garcia-Layana3Irene T. Molina-Martinez4Sergio Recalde5Michael J. Young6Budd A. Tucker7Rocío Herrero-Vanrell8Patricia Fernandez-Robredo9Irene Bravo-Osuna10Pharmaceutical Innovation in Ophthalmology (InnOftal), Research Group (UCM 920415), Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, SpainPharmaceutical Innovation in Ophthalmology (InnOftal), Research Group (UCM 920415), Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, SpainPharmaceutical Innovation in Ophthalmology (InnOftal), Research Group (UCM 920415), Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, SpainDepartment of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Harvard University, 20 Staniford Street, Boston, MA 02114, USAInstitute for Vision Research, Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA 52242, USAPharmaceutical Innovation in Ophthalmology (InnOftal), Research Group (UCM 920415), Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universidad de Navarra, 31008 Pamplona, SpainPharmaceutical Innovation in Ophthalmology (InnOftal), Research Group (UCM 920415), Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University, Plaza de Ramón y Cajal, s/n, 28040 Madrid, SpainWe assessed the sustained delivery effect of poly (lactic-co-glycolic) acid (PLGA)/vitamin E (VitE) microspheres (MSs) loaded with glial cell-derived neurotrophic factor (GDNF) alone (GDNF-MSs) or combined with brain-derived neurotrophic factor (BDNF; GDNF/BDNF-MSs) on migration of the human adult retinal pigment epithelial cell-line-19 (ARPE-19) cells, primate choroidal endothelial (RF/6A) cells, and the survival of isolated mouse retinal ganglion cells (RGCs). The morphology of the MSs, particle size, and encapsulation efficiencies of the active substances were evaluated. In vitro release, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability, terminal deoxynucleotidyl transferase (TdT) deoxyuridine dUTP nick-end labelling (TUNEL) apoptosis, functional wound healing migration (ARPE-19; migration), and (RF/6A; angiogenesis) assays were conducted. The safety of MS intravitreal injection was assessed using hematoxylin and eosin, neuronal nuclei (NeuN) immunolabeling, and TUNEL assays, and RGC in vitro survival was analyzed. MSs delivered GDNF and co-delivered GDNF/BDNF in a sustained manner over 77 days. The BDNF/GDNF combination increased RPE cell migration, whereas no effect was observed on RF/6A. MSs did not alter cell viability, apoptosis was absent in vitro, and RGCs survived in vitro for seven weeks. In mice, retinal toxicity and apoptosis was absent in histologic sections. This delivery strategy could be useful as a potential co-therapy in retinal degenerations and glaucoma, in line with future personalized long-term intravitreal treatment as different amounts (doses) of microparticles can be administered according to patients’ needs.https://www.mdpi.com/1424-8247/14/1/50retinal diseasesGDNFBDNFRPE migrationco-deliveryPLGA microspheres
spellingShingle Alicia Arranz-Romera
Maria Hernandez
Patricia Checa-Casalengua
Alfredo Garcia-Layana
Irene T. Molina-Martinez
Sergio Recalde
Michael J. Young
Budd A. Tucker
Rocío Herrero-Vanrell
Patricia Fernandez-Robredo
Irene Bravo-Osuna
A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
Pharmaceuticals
retinal diseases
GDNF
BDNF
RPE migration
co-delivery
PLGA microspheres
title A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
title_full A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
title_fullStr A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
title_full_unstemmed A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
title_short A Safe GDNF and GDNF/BDNF Controlled Delivery System Improves Migration in Human Retinal Pigment Epithelial Cells and Survival in Retinal Ganglion Cells: Potential Usefulness in Degenerative Retinal Pathologies
title_sort safe gdnf and gdnf bdnf controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells potential usefulness in degenerative retinal pathologies
topic retinal diseases
GDNF
BDNF
RPE migration
co-delivery
PLGA microspheres
url https://www.mdpi.com/1424-8247/14/1/50
work_keys_str_mv AT aliciaarranzromera asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT mariahernandez asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT patriciachecacasalengua asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT alfredogarcialayana asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT irenetmolinamartinez asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT sergiorecalde asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT michaeljyoung asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT buddatucker asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT rocioherrerovanrell asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT patriciafernandezrobredo asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT irenebravoosuna asafegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT aliciaarranzromera safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT mariahernandez safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT patriciachecacasalengua safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT alfredogarcialayana safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT irenetmolinamartinez safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT sergiorecalde safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT michaeljyoung safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT buddatucker safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT rocioherrerovanrell safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT patriciafernandezrobredo safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies
AT irenebravoosuna safegdnfandgdnfbdnfcontrolleddeliverysystemimprovesmigrationinhumanretinalpigmentepithelialcellsandsurvivalinretinalganglioncellspotentialusefulnessindegenerativeretinalpathologies